Evolus (EOLS) Operating Income (2017 - 2026)
Evolus' (EOLS) quarterly Operating Income came in at -$6.8 million in Q1 2026, up 54.86% YoY from -$4.4 million in Q1 2025, and down 262.27% on a QoQ basis from $4.2 million in Q4 2025.
Evolus (EOLS) Operating Income (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Operating Income data on file, last reported at -$6.8 million in Q1 2026.
- Quarterly Operating Income rose 54.86% year-over-year to -$6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.3 million (up 40.14% YoY) and the FY2025 annual result came in at -$32.7 million, up 5.08% from the prior year.
- Operating Income declined to -$6.8 million in Q1 2026, from $4.2 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $4.2 million in Q4 2025 to a low of -$21.3 million in Q2 2022.
- A 5-year average of -$11.1 million and a median of -$11.5 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income sank 292.47% — and 2025, when it surged 282.37%.
- Tracing EOLS's Operating Income over 5 years: stood at -$10.6 million in 2022, then rose by 18.82% to -$8.6 million in 2023, then soared by 73.2% to -$2.3 million in 2024, then surged by 282.37% to $4.2 million in 2025, then slumped by 262.27% to -$6.8 million in 2026.
- The last three Operating Income figures came in at -$6.8 million (Q1 2026), $4.2 million (Q4 2025), and -$11.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Evolus | 549.85 Mn | 504.68 Mn | 57.18 Mn | -4.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.54 Mn |
| Mar 31, 2026 | -6.85 Mn |
| Dec 31, 2025 | 4.22 Mn |
| Sep 30, 2025 | -11.50 Mn |
| Jun 30, 2025 | -10.21 Mn |
| Mar 31, 2025 | -15.17 Mn |
| Dec 31, 2024 | -2.31 Mn |
| Sep 30, 2024 | -15.47 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Mar 31, 2024 | -8.92 Mn |
| Dec 31, 2023 | -8.64 Mn |
| Sep 30, 2023 | -13.44 Mn |
| Jun 30, 2023 | -15.12 Mn |
| Mar 31, 2023 | -12.04 Mn |
| Dec 31, 2022 | -10.64 Mn |
| Sep 30, 2022 | -17.90 Mn |
| Jun 30, 2022 | -21.35 Mn |
| Mar 31, 2022 | -15.45 Mn |
| Dec 31, 2021 | -18.03 Mn |
| Sep 30, 2021 | -19.11 Mn |